Navigation Links
La Jolla Institute discovery could lead to new way to screen drugs for adverse reactions
Date:5/29/2012

SAN DIEGO (May 29, 2012) Adverse drug reactions are a major issue that cause harm, are costly and restrict treatment options for patients and the development of new drugs. A groundbreaking finding by researchers from the La Jolla Institute for Allergy & Immunology could lead to a new way to dramatically improve drug safety by identifying drugs at risk to cause potentially fatal genetic-linked hypersensitivity reactions before their use in man.

Hypersensitivity reactions are similar to allergic reactions, whereby the immune system responds too strongly to something foreign that is not infectious or dangerous. This response produces symptoms ranging from mild, such as rashes, to severe including anaphylactic shock, organ failure and even death.

La Jolla Institute scientist Bjoern Peters, Ph.D., led the study which illuminated, for the first time, the specific mechanism leading to HLA gene-linked hypersensitivity to the drug abacavir, a finding that will have widespread importance and applicability to the study of drug hypersensitivity in association with other drugs.

HLA is a gene that helps the immune system to identify if the body's own cells have been infected by foreign invaders such as viruses and bacteria. Individuals have many different variations of HLA. In the case of abacavir, a drug used to treat HIV, the majority of people who carry a particular HLA variant, known as HLA-B*57:01, may experience serious, and in some cases, life-threatening hypersensitivity reactions.

"Many drug hypersensitivity reactions are HLA-linked, meaning that they will occur much more often or even exclusively in individuals who have certain variants of the HLA gene," said Dr. Peters, adding that some gene variants appear to be more commonly associated with drug hypersensitivity. "The present system of clinical trials is very powerful in identifying side effects that occur in many people. However, HLA-linked hypersensitivity has bee
'/>"/>

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. La Jolla Institute scientist takes quest to conquer Type 1 diabetes to the next level
2. La Jolla Institute researchers identify pivotal immune cell in Type 1 diabetes in humans
3. La Jolla Institute joins Sanford Consortium for Regenerative Medicine
4. La Jolla Institute discovers novel mechanism for preventing infection via bodys mucosal borders
5. La Jolla Institute discovers previously unknown cell interaction key in immune system attacks
6. La Jolla Institute opens major RNAi center for identifying genetic triggers of disease
7. La Jolla Institute identifies new therapeutic target for asthma, COPD and other lung disorders
8. La Jolla Institute-led team illuminates cell pathway key to insulin resistance in Type 2 diabetes
9. La Jolla Institute validates Type 1 diabetes computer models predictive success through lab testing
10. La Jolla Institute scientist Klaus Ley receives Malpighi award
11. La Jolla Institute scientist leads team which discovers important new player in diabetes onset
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... The most comprehensive study to date of the ... to more effective vaccine strategies and reveals surprising ... new results could alter public health strategies to ... worldwide each year. , Genomic analysis of 343 ... from around the world collected over the last ...
(Date:4/23/2014)... technique used to read quickly. It involves visual ... words and/ or sentences. Similarly to humans, biological ... "read" genetic information. Genes that need to be ... the encoding message, the easier it will be ... Gulbenkian de Cincia (IGC, Portugal) and Centre for ...
(Date:4/22/2014)... lead a five-year, $3 million study to determine whether ... transport of dissolved organic matter (DOM) through the Connecticut ... chemical composition and water quality of the watershed and ... Science Foundation,s MacroSystems Biology program, researchers will collect data ... in Canada and runs through five U.S. states, before ...
Breaking Biology News(10 mins):Impact of whooping cough vaccination revealed 2Cell division speed influences gene architecture 2Connecticut River watershed study will assess impacts of extreme rain events 2Connecticut River watershed study will assess impacts of extreme rain events 3
... of Illinois researchers identified the top pathogens, pests and ... Food Security. Soybean aphid, soybean rust, soybean cyst nematode, ... red leaf blotch, were featured as some of the ... and in the future. "Enormous potential exists to ...
... 2011) The remoteness and resource limitations of spaceflight ... solution is ultrasound. Scientists with the National ... expand the use of ultrasound during spaceflight and on ... include techniques that streamline training and help remote experts ...
... For most people, listening to the ocean means ... a sandy beach. But for researchers studying everything ... mapping to guiding robots trying to repair leaking undersea ... side underwater can reveal volumes of valuable ...
Cached Biology News:New and old threats to soybean production 2Space research gives birth to new ultrasound tools for health care in orbit, on Earth 2Space research gives birth to new ultrasound tools for health care in orbit, on Earth 3Space research gives birth to new ultrasound tools for health care in orbit, on Earth 4'Orca ears' inspire Stanford researchers to develop ultrasensitive undersea microphone 2'Orca ears' inspire Stanford researchers to develop ultrasensitive undersea microphone 3'Orca ears' inspire Stanford researchers to develop ultrasensitive undersea microphone 4
(Date:1/15/2014)... Look inside the new Preferred Solutions® ... lab, from fluid handling to instruments to supplies. Many ... you order. , Preferred Solutions features a full ... L/S® model for precise flow control and dispensing to ...
(Date:1/15/2014)... California , January 15, 2014 Oxford ... today announced the appointment of Thomas C Reynolds MD, PhD ... years, development experience gained in the biotechnology industry, most recently ... am delighted to welcome Tom at this transformative time for ...
(Date:1/15/2014)... 2014 This webinar will focus on ... safety assessment in biosimilars. , Regulatory frameworks are evolving ... development, however the complex nature of biopharmaceuticals makes the ... efficacy extremely challenging. Based on the specific aspects of ...
(Date:1/15/2014)... Houston, TX (PRWEB) January 15, 2014 ... Alzheimer’s disease, and about 1 in 3 seniors will ... ( source ). These jaw-dropping figures have shocked many ... function and, hopefully, help prevent these tragic age-related cognitive ...
Breaking Biology Technology:Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2
... America,s Heartland, the,weekly public television series that celebrates the ... season this fall. Twenty-two new half-hour segments will ... middle of the third season,America,s Heartland will have profiled ... 50 states. The program is made possible with ...
... PALO ALTO, Calif., Oct. 3 Alexza,Pharmaceuticals, Inc. ... corporate,presentation will be webcast live during the 4th ... at 4:30 p.m. Eastern Time. The presentation,will be ... may be accessed,under the Investor Relations tab at ...
... to 45%, GURGAON, India, Oct. 3 Ranbaxy ... the,signing of Definitive Agreements, providing for an increase in ... at a price of Rs. 160 per share,aggregating to ... shares from the existing Promoters (b) Preferential Offer ...
Cached Biology Technology:America's Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers 2The 4th Annual BIO Investor Forum to Webcast Alexza's Corporate Presentation 2Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology 2Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology 3
... SPD101B is a no-frills, basic SpeedVac concentrator ... economically priced, this unit still features a ... digitial display of time and heat. It ... and accepts a wide variety of different ...
... to have active, real-time sample temperature monitoring. ... the worlds first, fully modular SpeedVac System. ... together to form an integrated unit or ... also the first SpeedVac to have sample ...
Digital display of time, vacuum and temperature , Dual vacuum control of ramping rate and ultimate level , Comes complete with RH40-12 (40 x 1.5 ml) Rotor and (2) Glass Condensation Flasks. ...
... Acid Resistant SpeedVac Model SPD131DDA , ... , The SPD131DDA is designed to handle the ... a new slim design, digital display, dual independent ... TEFLON coated chamber and vapor pathway. , , ...
Biology Products: